Monday, April 29, 2019

Cipla gets final approval for generic version of Letairis

Ciplas Ambrisentan Tablets 5mg & 10mg is AB-rated generic therapeutic equivalent version of Gilead Sciences, Incs Letairis, the company said in the filing.

from India Infoline News Service http://bit.ly/2vrObZA

No comments:

Post a Comment